Welcome to our dedicated page for The Beachbody news (Ticker: BODI), a resource for investors and traders seeking the latest updates and insights on The Beachbody stock.
The Beachbody Company, Inc. reports developments in fitness programming, nutrition products, supplements, and digital wellness subscriptions under the BODi brand. The company, formerly known as Beachbody, is associated with structured home fitness programs such as P90X, INSANITY and 21 Day Fix, as well as the Shakeology protein and superfood nutrition line.
Recurring updates cover new digital workout programs, nutrition-led product extensions, retail distribution for Shakeology, P90X-branded supplements, subscription offerings, and quarterly financial results. Company news also reflects BODi’s focus on combining fitness content, nutritional products, and community-based accountability for consumers seeking home-based health and wellness routines.
The Beachbody Company (NYSE: BODI), a leading fitness and nutrition company, has scheduled its fourth quarter 2024 earnings release for Thursday, March 27, 2025, after market close. The company will host a conference call at 5:00 p.m. Eastern Time to discuss the results.
Investors can join via toll-free dial-in at (833) 470-1428 (U.S. & Canada) with conference ID 112560, or through the live webcast on the company's investor relations website. A replay will be available from March 27 through April 3, 2025, accessible at (866) 813-9403 with passcode 284281.
The Beachbody Company (NYSE: BODI) has announced its participation in the upcoming 2025 ICR Conference. The company's leadership team, including Executive Chairman Mark Goldston, Co-Founder and CEO Carl Daikeler, and Interim CFO Brad Ramberg, will engage in a Fireside Chat on Tuesday, January 14, 2025, at 1:30pm EST.
Interested parties can access a live webcast of the presentation through the Investors section of the company's website. Investors seeking to schedule meetings with management are advised to contact their ICR representatives.
BODi (NYSE: BODI) has launched 'Belle Vitale,' a comprehensive 12-week lifestyle program designed by fitness expert Autumn Calabrese to address women's hormone health issues. The program combines fitness, nutrition, and stress reduction with proprietary supplements.
The program includes a 3-phase nutrition plan, 20 digital workouts combining Track Pilates and strength training, two proprietary supplement blends, and stress management tools through the Breathwrk app. Clinical testing showed participants experienced improvements in cortisol levels, metabolic markers, and weight loss.
The program targets common hormone imbalance symptoms affecting approximately 80% of women, including weight gain, hot flashes, irregular cycles, sleep disturbances, and mood swings.
Beachbody (BODi) reported Q3 2024 financial results with total revenue of $102.2 million, down 20.3% from prior year. The company announced a strategic shift from multi-level marketing to a single-level affiliate network. Key metrics include: gross margin of 67% (up 880bps), net loss of $12.0 million (improved from $32.7 million), and positive Adjusted EBITDA of $10.1 million. Digital subscriptions reached 1.11 million, while nutritional subscriptions were 0.13 million. The company provided Q4 2024 guidance with revenue between $77-87 million and Adjusted EBITDA of $2-6 million.
The Beachbody Company, Inc. (NYSE: BODI), a leading health and fitness company, has announced its plans to release third quarter 2024 financial results. The earnings report will be made public on Tuesday, November 12, 2024, after the U.S. stock market closes. Following the release, the company will host a conference call at 5:00 p.m. Eastern Time to discuss the results.
Interested parties can join the call using the toll-free dial-in number (833) 470-1428 for U.S. & Canada, with the conference ID 396510. A live webcast will also be available on the company's investor relations website. For those unable to attend, a replay will be accessible from November 12 to November 19, 2024, using the toll-free replay number (866) 813-9403 with passcode 516534.
The Beachbody Company (NYSE: BODI) announced a strategic shift in its core business model, transitioning from a Multi-Level Marketing (MLM) Network to a single-level Affiliate Program launching November 1, 2024. This change aims to streamline operations and position the company for profitable growth. Key points include:
- Reducing costs and broadening distribution channels
- Lowering the revenue break-even point by ~47%, from $430 million to $225 million annually
- Reducing workforce by 33%, expecting $54 million in annualized overhead savings
- Expanding direct-to-consumer, Amazon, and partnership-driven sales channels
- Reaffirming Q3 2024 guidance: revenue of $97-107 million, net loss of $9-13 million (excluding restructuring charges), and Adjusted EBITDA of $2-6 million
The company views this evolution as necessary to adapt to current market dynamics and consumer preferences, aiming to simplify customer acquisition and reward sellers directly for their efforts.
BODi, a leading fitness and nutrition company, has named Dean Muhtadi, former professional football player and wrestler, as its newest Brand Ambassador. Muhtadi, known for his wrestling persona 'Mojo Rawley', will promote BODi's fitness programs and nutrition benefits after achieving remarkable results through the LIIFT4 program.
Muhtadi's journey with LIIFT4, a program combining weightlifting and high-intensity interval training, has been shared on his social media platforms, reaching his 365K+ Instagram followers. He and his cousin Laith Chaz have been motivating their audience with a mix of intense workouts and entertaining content.
As a Brand Ambassador, Muhtadi will participate in various promotional activities, including social media campaigns, virtual workout sessions, and special events, aiming to inspire others to achieve their fitness goals with BODi's programs.
BODi (NYSE: BODI) has announced a strategic partnership with Truemed, enabling qualifying customers to use pre-tax HSA or FSA funds for purchasing BODi nutritional supplements and fitness offerings. This collaboration allows customers to save up to 40% on BODi products, including Shakeology and the Beachbody Performance line. To qualify, customers must complete an online medical assessment with Truemed to obtain a Letter of Medical Necessity (LMN), valid for one year. The partnership aims to make health and wellness more accessible to the over 40% of Americans with HSA/FSA accounts. Eligible customers can receive reimbursement for their purchases by submitting their LMN and BODi receipts to their HSA or FSA administrator.
BODi (NYSE: BODI) launched a new fitness program, '4 Weeks of Focus', featuring fitness trainer Kelsey Heenan and actress Shay Mitchell. Available with a BODi subscription or separately for $59.95, this program includes 20 unique workouts over four weeks, designed for all fitness levels. The workouts blend resistance with cardio, enhancing calorie burn and muscle gains.
Shay Mitchell's impressive results were highlighted across major media outlets, emphasizing strength and health benefits. The program aims to deliver substantial progress in just 30 minutes a day, five days a week.
Beachbody (BODi) reported its Q2 2024 financial results, revealing improved performance metrics. Total revenue reached $110.2 million, surpassing the guidance midpoint but reflecting an 18.4% decline year-over-year. Net loss was $10.9 million, significantly better than the previous year’s loss of $25.7 million. Adjusted EBITDA improved to $4.9 million, marking the third consecutive quarter of positive results.
While digital revenue decreased to $58.8 million, nutritional revenue fell to $50.1 million. Operating expenses were reduced to $85.9 million, down from $106.9 million. The company also reported its lowest net loss since going public and an overall gross margin of 69%, the best since 2021. Cash provided by operating activities was $8.2 million, marking a positive shift from the prior year’s $14.4 million used in operations.
The company projects Q3 2024 revenue between $97 million and $107 million, with adjusted EBITDA ranging from $2 million to $6 million.